Position in LGND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,788,437
+$658,618 QoQ
Shares Held
5,658
-0.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#160
of 414 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $22,827,015 across 21 Biotechnology names. LGND ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,887 | $2,678,471 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,938 | $2,452,852 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,691 | $2,301,486 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
This page
|
5,658 | $1,788,437 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
49,246 | $1,742,815 | |
| 6 | EXEL |
Exelixis, Inc.
|
30,229 | $1,644,759 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,398,754 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
4,647 | $1,324,255 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,788,437 | 5,658 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,129,819 | 5,659 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,069,758 | 5,658 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,002,258 | 5,658 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $643,201 | 5,658 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $623,059 | 5,926 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,964 | 37 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,703 | 37 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,117 | 37 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,704 | 37 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,642 | 37 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $8,808 | 147 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,313 | 254 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $18,169 | 247 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $9,352 | 140 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,174 | 153 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,427 | 16 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,349 | 12 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,853 | 12 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $2,507 | 18 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,574 | 12 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,829 | 12 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,193 | 12 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $5,480 | 49 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $42,176 | 580 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||